MoldCo Review: Service Facts and Evidence Limits

MoldCo is a virtual membership platform that advertises clinician services, optional laboratory products, symptom tracking, messaging, and recurring product shipments. The company frames its model around CIRS and mold-related health concerns. CIRS is contested and is not accepted by mainstream allergy and toxicology bodies. The service description does not validate the clinical framework or its optional tests.

MoldCo publishes an onboarding sequence that includes:

• A company intake questionnaire about symptoms, building history, and medical background.
• A company-described provider review and proposed plan.
• Customer approval before listed products ship or are billed.
• Ongoing messaging, symptom tracking, plan changes, and optional product shipments.

These are company-reported workflow facts. They do not establish that CIRS is a validated diagnosis or that an optional body test supports causation or treatment decisions.

MoldCo describes clinician services and three optional testing categories.

1. Home dust test (HERTSMI-2)

MoldCo lists a HERTSMI-2-style dust product in single-room, three-room, and five-room formats. The score is not a diagnosis, clearance, safe-occupancy, or re-entry determination. EPA says ERMI, the related research index, is not recommended for consumer home testing.

2. Blood panel (company-described markers)

MoldCo describes this as a blood panel with varying marker counts, drawn at Labcorp. Those are company product claims. CLIA laboratory status does not establish that a panel diagnoses mold-related illness, and this review does not endorse CIRS interpretations.

3. Genetic risk test (HLA gene typing)

MoldCo lists an HLA gene test and links it to mold-related reactions. That is the company's framing, not a validated diagnosis, causal finding, or basis for a treatment decision.

The company also lists virtual visits, messaging, symptom tracking, proposed plans, and access to recurring products. Those services do not validate CIRS, establish illness or causation, identify a building source, or replace a qualified building investigation.

MoldCo publishes a membership price and separate charges for visits, tests, and recurring products. These listed figures can change.

MoldCo describes a combined monthly range around 150 to 300 dollars once membership and products are included, states that services are HSA and FSA eligible, and says there is no long-term commitment. It does not advertise standard insurance coverage. Price, payment treatment, and subscription terms do not validate CIRS or any optional test.

Company-reported credentials

MoldCo identifies clinicians and a reference laboratory in its marketing. Credentials and CLIA laboratory operations do not validate CIRS, establish a causal mold-illness diagnosis, or validate the company's optional body tests.

The framework is contested

MoldCo's CIRS framing is contested and is not accepted by mainstream allergy and toxicology bodies. This review does not present it as an established diagnosis, a basis for causal conclusions, or a treatment pathway.

MoldCo cites a company metric that 95 percent of a small tracked group reported fewer symptoms in 30 days. The company disclaimer describes a group of about 61 patients and a self-reported symptom count. That marketing metric is not independent clinical validation and does not establish an objective treatment effect, causation, or safe occupancy.

• MoldCo lists virtual access in most states and shipping for some products.
• The company identifies clinicians and says blood panels are processed through Labcorp.
• MoldCo lists a 79-dollar monthly membership, a first month at no charge, and no long-term commitment.
• The platform description includes intake, visits, messaging, symptom tracking, tests, and recurring products.
• The company lists a HERTSMI-2-style dust product, blood panels, and an HLA test.
• MoldCo states that its services are HSA and FSA eligible.

None of these service facts establishes clinical validity or a reliable building decision.

• CIRS is contested and is not accepted by mainstream allergy and toxicology bodies as an established diagnosis or treatment pathway.
• Optional body tests do not establish illness, exposure source, causation, or treatment need.
• A HERTSMI-2-style dust score does not establish remediation scope, clearance, safe occupancy, or re-entry.
• CLIA laboratory operations and clinician credentials do not establish clinical validity.
• MoldCo does not perform a building investigation or locate a moisture source.
• Membership, visits, tests, and recurring products can create substantial out-of-pocket costs.
• The company does not clearly publish turnaround times for all listed tests.

MoldCo is not a suitable source for an evidence-based diagnosis, causal conclusion, treatment pathway, remediation scope, clearance, or occupancy decision. Its optional body tests cannot establish illness or a building source. Its dust score cannot establish safe occupancy or re-entry. Building questions require a qualified building investigation, and health concerns require evaluation under established medical guidance.

MoldCo vs a standard doctor or allergist

A licensed clinician can evaluate symptoms using established guidance and recognized methods for conditions such as allergy and asthma. MoldCo is a paid membership built around a contested CIRS framework. Neither a clinical visit nor a body test performs a building investigation.

MoldCo vs a home mold test kit

A home mold test kit samples a limited location or material from a building. It does not establish a complete source, health cause, remediation scope, clearance, or safe occupancy. MoldCo's HERTSMI-2-style dust product also has those decision limits. See our guide on how to test for mold.

MoldCo vs specialty lab tests (ERMI and mycotoxin panels)

An ERMI test applies a research index to mold-DNA measurements from dust, while a urine mycotoxin panel reports compounds in urine. EPA does not recommend ERMI for routine consumer use, and CDC states urine mycotoxin tests are not FDA-approved for clinical use. Neither establishes illness, causation, source location, clearance, or safe occupancy.

MoldCo vs professional mold inspection and remediation

A qualified building professional can investigate building history, moisture, accessible materials, and a defined sampling question. MoldCo does not perform that work. Its service and test results do not establish remediation scope or clearance.

Bottom line on comparisons: MoldCo is a paid membership, not a building investigation. Its contested CIRS framing and optional body tests should not be used to establish a diagnosis, source, causation, clearance, or safe occupancy.

MoldCo publishes intake, virtual-visit, plan-approval, billing, messaging, cancellation, and product-shipment terms. Those are service-process facts, not medical guidance. This review does not recommend enrolling or ordering optional tests. MoldCo outputs do not establish diagnosis, causation, treatment need, source, remediation scope, clearance, or safe occupancy.

MoldCo publishes membership, clinician-service, optional-product, payment, and subscription details. Those facts do not validate its CIRS framing or optional tests. CIRS is contested and is not accepted by mainstream allergy and toxicology bodies as an established diagnosis or treatment pathway. Do not use the service, body-test results, or dust scores to establish illness, causation, treatment need, a building source, remediation scope, clearance, safe occupancy, or re-entry.

MoldCo reviews can tell you about price, service and billing experience, but they cannot tell you whether the CIRS approach behind the service is valid. That question depends on medical evidence, not on how customers felt about the checkout.

Customer feedback lives on Trustpilot, which is linked in Sources below. Mold Co reviews there are one person's experience each. This page does not quote a star rating or a review count, because those numbers change. Open the live page if you want the current picture.

What a review can tell you

• What the person paid, and whether the membership, visit and test charges matched what the company lists.
• How messaging with the clinic went and how fast replies came.
• Whether canceling was easy. MoldCo says there is no long-term commitment.
• Whether recurring products arrived and were billed the way the person expected.

What a review cannot tell you

A review cannot show that CIRS is an established diagnosis. The American Academy of Allergy, Asthma and Immunology and the American College of Medical Toxicology position papers in Sources do not treat it that way. A review also cannot show that a blood, genetic or dust result explains someone's symptoms, and it cannot tell you whether there is mold in your building.

MoldCo is a real company with published prices and blood panels processed through Labcorp, but its CIRS framing is contested and not accepted by mainstream allergy and toxicology bodies.

Two questions hide inside "is MoldCo legit." The first is whether the business is real. The company publishes a membership price of 79 dollars per month with the first month free, lists its visit and test prices, and says services are HSA and FSA eligible. PR Newswire and Fierce Healthcare, both in Sources, reported its seed funding. The same answer applies if you searched "is mold co legit."

The second question is whether the medical model is proven. It is not. CIRS is contested, and CDC and FDA do not recognize unvalidated body tests as a way to diagnose mold-related illness. A professional checkout page and clinician names do not change that.

So the fair reading is mixed. As a paid virtual membership it exists and bills as described on its own site. As evidence for a diagnosis, a cause, or a building decision, it does not hold up. If your real question is whether mold is growing in your home, MoldCo does not investigate buildings or find moisture sources.

Read a review for what the person paid, what they got, and how canceling went, not for claims about what caused their symptoms.

Use this short checklist on any MoldCo review, on Trustpilot or anywhere else:

1. Look for the charges. The listed prices are 79 dollars per month for membership, about 129 dollars for a provider visit, dust tests from about 199 dollars, genetic testing from about 224 dollars, and recurring products at roughly 107 to 313 dollars per month. A review that names none of these is telling you little about cost.
2. Check what was actually bought. Membership alone is different from membership plus tests plus monthly products.
3. Look at how canceling went, since the company says there is no long-term commitment.
4. Discount any claim that a test proved mold caused an illness. Body tests and dust scores do not establish causation, and one customer's account cannot change that.
5. Be careful with a review that credits the service for feeling better. It cannot show the service was the cause.

Reviews also say nothing about your building. Mold Scanner checks a photo for signs of mold growth, which is a first look at a visible spot, not a diagnosis.